SKI Market

Indian Indices

Sensex

83,382.71 -244.98
( -0.29%)

Global Indices

Nasdaq

49,156.99 -56.01
(-0.11%)

Dow Jones

6,945.95 -38.79
(-0.56%)

Hang Seng

53,810.56 -530.67
(-0.98%)

Nikkei 225

10,240.27 55.92
(0.55%)

Forex

USD-INR

90.25 0.03
(0.03%)

EUR-INR

105.19 0.24
(0.23%)

GBP-INR

121.43 0.56
(0.46%)

JPY-INR

0.57 0.00
(-0.55%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5631051

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

18.34

99024.72

EPS(TTM)

Face Value()

Div & Yield %

64.68

0.67

Back

Damodar Industries standalone net profit rises 55.41% in the September 2025 quarter

Oct 15,2025

Net profit of Damodar Industries rose 55.41% to Rs 1.15 crore in the quarter ended September 2025 as against Rs 0.74 crore during the previous quarter ended September 2024. Sales rose 26.02% to Rs 121.89 crore in the quarter ended September 2025 as against Rs 96.72 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	121.89	96.72	26
OPM %	6.64	7.71	-
PBDT	6.04	6.19	-2
PBT	1.81	1.05	72
NP	1.15	0.74	55

83,382.71 -244.98 ( -0.29%)

49,156.99 -56.01 (-0.11%)

6,945.95 -38.79 (-0.56%)

53,810.56 -530.67 (-0.98%)

10,240.27 55.92 (0.55%)

90.25 0.03 (0.03%)

105.19 0.24 (0.23%)

121.43 0.56 (0.46%)

0.57 0.00 (-0.55%)